^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
Oncomine™ Myeloid MRD Assays

Type:
Laboratory Developed Test
Related tests:
Evidence

News

4ms
Evaluation of the Thermo Fisher Oncomine Myeloid MRD DNA Assay on the Ion Torrent Platform (ASH 2023)
The user-friendly workflow and integrated informatics pipeline offer opportunities for streamlined testing and interpretation of results. The Ion Torrent Myeloid MRD DNA assay is a powerful new tool for MRD detection across a growing myeloid disease target landscape.
Oncomine™ Myeloid MRD Assays
over1year
Thermo Fisher Scientific introduces highly sensitive research assays for measurable residual disease detection in myeloid malignancies (Thermo Fisher Scientific Press Release)
"Thermo Fisher Scientific...launched a next-generation sequencing (NGS)-based assay for research in myeloid measurable residual disease (MRD). As the first NGS-based tests to support both DNA and RNA input, the Ion Torrent Oncomine Myeloid MRD Assays (RUO) provide a comprehensive and highly sensitive MRD assessment from blood and bone marrow samples."
Launch
|
Oncomine™ Myeloid MRD Assays